Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Here, Let Me Help

<< Previous

Bullboard Posts

Next >>

Comment by pabalooon Dec 01, 2020 8:09am

164 Views

Post# 32007728

RE:Here, Let Me Help

Hey Jizz Swapper the Bozo the friggen clown. You are indeed a piece of shot off the end of my loaf. Your advice is of no use since there are 3 people here none of which listen to your scum bag opinion. So far you have been wrong on everything you spew. I love the fact you have lost your shirt on HEM and the other sticks you own! Ha ha now flock off you a hole. This stock bounces like a rubber ball I love it. If your smart buyin and sell for a nice double in a few weeks. That's the nature of this company. Watch and learn idiot.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario